Vinay Prasad, an epidemiologist and vocal critic of FDA policies, has been appointed to oversee vaccines, gene therapies, and blood supply regulation. His replacement of Peter Marks follows a contentious period under the Trump administration. Prasad's role comes at a crucial time when public trust in vaccines is deteriorating, especially with Robert F. Kennedy Jr. leading the Department of Health and Human Services. Prasad advocates for higher safety standards, including randomized trials for COVID-19 vaccines, but faces pushback from experts regarding feasibility and urgency.
Vinay Prasad's appointment as the FDA's top regulator of vaccines marks a critical moment as public trust in vaccines wanes and safety policies face scrutiny.
Prasad has emphasized the need for randomized clinical trials for annual coronavirus vaccines, aligning with some administration signals but drawing criticism from public health experts.
Collection
[
|
...
]